Comparison of the effects of gonadotropin-releasing hormone and raloxifeneon the size of uterine leiomyoma

Journal Title: Chronic Diseases Journal - Year 2014, Vol 2, Issue 1

Abstract

BACKGROUND: Uterine leiomyoma is a prevalent benign tumor. Several studies have shown the positive effects of raloxifene in the treatment of leiomyomas. Since raloxifene has fewer side effects than the gonadotropin-releasing hormone (GnRH) agonist, if proven effective, it can be applied easily. This study aimed to compare the medical effects of raloxifene and GnRH on uterine leiomyoma size. METHODS: This clinical trial included 53 women with uterine leiomyoma. Participants were randomly divided into 2 groups of raloxifene and GnRH. The GnRH group received 1 dose per month (intramuscular injection) and the raloxifene group received 60 mg raloxifene orally/day for 3 months. The size of the leiomyoma, prior and during the intervention, was determined by a sonographist. During the study, repeated measurement was used for comparing the trend of alterations in the tumor size. RESULTS: Analysis of changes in leiomyoma tumor size (log of tumor size) by repeated measurement showed that decrease in tumor size in the raloxifene group was significantly higher than GnRH group (P = 0.042). The trends of changes in endometrial thickness were different in the 2 groups and the reduction of thickness was more significant in the GnRH group (P = 0.026). CONCLUSION: This study showed that raloxifene is an appropriate medicine to reduce the size of uterine leiomyoma and is more effective than GnRH.

Authors and Affiliations

Farnaz Zandvakili, Fariba Seyedoshohadaie, Masoumeh Rezaiee, Nasrin Soofizade, Ebrahim Ghaderi

Keywords

Related Articles

Kikuchi-Fujimoto disease in a young female with discoid lupus and alopecia

Kikuchi-Fujimoto disease is an uncommon, benign, autoimmune condition characterized by lymphadenopathy, fever, and neutropenia. It is a self-contained condition of unidentified etiology. A 38-year-old female of Iranian K...

Staphylococcal protein A (spa) typing of Staphylococcus aureus isolates causing nosocomial infections

BACKGROUND: Staphylococcal protein A (spa) typing is a typing method based on the DNA sequence analysis of staphylococcal protein A gene. The purpose of this study was to do molecular typing of Staphylococcus aureus isol...

Investigating the relationship between the level of serum albumin and body mass index, as nutritional indicators, with dialysis adequacy in patients under hemodialysis

BACKGROUND: Patients with end-stage renal disease (ESRD) who undergo hemodialysis have many complications; one of the most important of which is malnutrition, which affects these patients’ quality of life. The aim of thi...

Inhibition of cell proliferation and increased-apoptosis of AGS and SNU-5 cancer cells following small interfering RNA (siRNA)-mediated down-regulation of vascular endothelial growth factor receptor 1 (VEGFR1)

BACKGROUND: Angiogenesis is vital for development of normal tissue and wound healing; but it play an important role in development of some diseases such as different types of cancer. Vascular endothelial growth factor (V...

The relationship between the adequacy of hemodialysis and laboratory parameters

BACKGROUND: The present study was conducted in order to evaluate the factors affecting the adequacy of dialysis and determine the relationship of dialysis adequacy with laboratory parameters. METHODS: This descriptive st...

Download PDF file
  • EP ID EP284976
  • DOI -
  • Views 116
  • Downloads 0

How To Cite

Farnaz Zandvakili, Fariba Seyedoshohadaie, Masoumeh Rezaiee, Nasrin Soofizade, Ebrahim Ghaderi (2014). Comparison of the effects of gonadotropin-releasing hormone and raloxifeneon the size of uterine leiomyoma. Chronic Diseases Journal, 2(1), 46-51. https://europub.co.uk/articles/-A-284976